Al-Alwan, A., Aloqaily, M., Ramesh, M., Awidi, M., Thanikachalam, K. (2026). Real-world outcomes of first-line lenvatinib versus sorafenib in advanced HCC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.e16228